Sirinavin S, Garner P
Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Rama 6, Bangkok, Thailand, 10400.
Cochrane Database Syst Rev. 2000(2):CD001167. doi: 10.1002/14651858.CD001167.
Antibiotic treatment of salmonella infections aims to shorten illness and prevent serious complications. There are also concerns about increasing antibiotic drug resistance.
The objective of this review was to assess the effects of antibiotics in adults and children with diarrhoea who have salmonella.
We searched the Cochrane Infectious Diseases Group trials register, the Cochrane Controlled Trials Register, Medline, Science Citation Index, African Index Medicus, Lilacs, Extra Med and reference lists of relevant articles. We also contacted experts in the field.
Randomised and quasi-randomised trials comparing antibiotic therapy with placebo or no antibiotic therapy for salmonella infections in symptomatic or asymptomatic adults or children. Typhoid and paratyphoid salmonella infections were excluded.
Trial quality assessment and data were extracted independently by two reviewers.
Twelve trials involving 778 participants (with at least 258 infants and children) were included. There were no significant differences in length of illness, diarrhoea or fever between any antibiotic regimen and placebo. The weighted mean difference for length of illness was -0.07 days, 95% confidence interval -0.55 to 0.40; diarrhoea -0.03 days, 95% confidence interval -0.53 to 0.48; fever -0.45 days, 95% confidence interval -0. 98 to 0.08. Antibiotic regimens resulted in more negative cultures during the first week of treatment. Relapses were more frequent in those receiving antibiotics, and there were more cases with positive cultures in the antibiotic groups after three weeks. Adverse drug reactions were more common in the antibiotic groups (odds ratio 1.67, 95% confidence interval 1.05 to 2.67).
REVIEWER'S CONCLUSIONS: There appears to be no evidence of a clinical benefit of antibiotic therapy in otherwise healthy children and adults with non-severe salmonella diarrhoea. Antibiotics appear to increase adverse effects and they also tend to prolong salmonella detection in stools.
沙门氏菌感染的抗生素治疗旨在缩短病程并预防严重并发症。同时也担心抗生素耐药性增加。
本综述的目的是评估抗生素对患有沙门氏菌的腹泻成人和儿童的疗效。
我们检索了Cochrane传染病组试验注册库、Cochrane对照试验注册库、Medline、科学引文索引、非洲医学索引、Lilacs、Extra Med以及相关文章的参考文献列表。我们还联系了该领域的专家。
比较抗生素治疗与安慰剂或不使用抗生素治疗对有症状或无症状成人或儿童沙门氏菌感染的随机和半随机试验。伤寒和副伤寒沙门氏菌感染被排除。
由两名评价员独立进行试验质量评估和数据提取。
纳入了12项试验,涉及778名参与者(至少258名婴儿和儿童)。任何抗生素治疗方案与安慰剂在病程、腹泻或发热方面均无显著差异。病程的加权平均差为-0.07天,95%置信区间为-0.55至0.40;腹泻为-0.03天,95%置信区间为-0.53至0.48;发热为-0.45天,95%置信区间为-0.98至0.08。抗生素治疗方案在治疗第一周导致更多阴性培养结果。接受抗生素治疗的患者复发更频繁,三周后抗生素组培养结果阳性的病例更多。抗生素组药物不良反应更常见(比值比1.67,95%置信区间1.05至2.67)。
对于其他方面健康的非重症沙门氏菌腹泻儿童和成人,似乎没有证据表明抗生素治疗有临床益处。抗生素似乎会增加不良反应,并且还倾向于延长粪便中沙门氏菌的检测时间。